Cardinal Health (CAH) Surged Following Improved Specialty Mix in Pharma

2 days ago 3

Soumya Eswaran

Tue, March 24, 2026 astatine 8:37 AM CDT 3 min read

Brown Advisory, an concern absorption company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The Strategy lagged the Russell Midcap® Growth Index successful the 4th fourth owed to banal selection. The show was successful enactment with expectations for the afloat year. The steadfast believes that the Strategy underperformed successful 2025 due to the fact that it did not ain Palantir Technologies Inc (PLTR). The Strategy focuses connected achieving coagulated risk-adjusted returns by investing successful high-quality compounders with just valuations and marketplace capitalizations betwixt $2 cardinal and $50 cardinal astatine the clip of purchase. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Brown Advisory Mid-Cap Growth Strategy highlighted Cardinal Health, Inc. (NYSE:CAH) arsenic 1 of its starring contributors. Cardinal Health, Inc. (NYSE:CAH) is simply a healthcare services and products institution that operates done Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution segments. On March 23, 2026, Cardinal Health, Inc. (NYSE:CAH) banal closed astatine $206.40 per share. One-month instrumentality of Cardinal Health, Inc. (NYSE:CAH) was -8.66%, and its shares gained 55.48% implicit the past 52 weeks. Cardinal Health, Inc. (NYSE:CAH) has a marketplace capitalization of $48.569 billion.

Brown Advisory Mid-Cap Growth Strategy stated the pursuing regarding Cardinal Health, Inc. (NYSE:CAH) successful its 4th fourth 2025 capitalist letter:

"Cardinal Health, Inc. (NYSE:CAH): Distributes pharmaceuticals and engages successful manufacturing & merchantability of medical, surgical and laboratory supplies. Cardinal (CAH) delivered a beardown fiscal archetypal quarter, driven by improved specialty premix successful Pharma, coagulated request successful atomic and location health, and continued borderline betterment successful Medical. Results were beardown capable to punctual an aboriginal guidance increase, with further upside imaginable pursuing the margin- and net-accretive Solaris acquisition."

Wells Fargo Raises Outlook connected Cardinal Health (CAH), Cites Broad Business Strength

Cardinal Health, Inc. (NYSE:CAH) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 60 hedge money portfolios held Cardinal Health, Inc. (NYSE:CAH) astatine the extremity of the 4th quarter, up from 55 successful the erstwhile quarter. Cardinal Health, Inc.'s (NYSE:CAH) 2nd 4th of fiscal 2026 gross accrued 19% year-over-year to $66 billion. While we admit the imaginable of Cardinal Health, Inc. (NYSE:CAH) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article